Home › Myasthenia Gravis › Illinois
Myasthenia Gravis clinical trials in Illinois
12 studies for Myasthenia Gravis are looking for participants at sites in Illinois.
Cities in Illinois
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10105, O'Fallon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07463521Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- HSHS St. Elizabeth's Hospital, O'Fallon
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 25, 2026 · NCT07217587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
- HSHS Medical Group - St. Elizabeth's Hospital, O'Fallon
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07501702RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Northwestern Memorial Hospital, Chicago
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Aug 13, 2026 · NCT06359041Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Chicago
- Aurinia Investigational Site, O'Fallon
RecruitingPhase 1/2
Ages 18 to 85 · All sexes · Updated Aug 3, 2026 · NCT07596901Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1054, Schaumburg
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Hospital Sisters Health System Medical, O'Fallon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT06456580A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Research Site, Chicago
- Research Site, Schaumburg
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT07221838Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital, Chicago
RecruitingPhase 2/3
Ages 2 to 18 · All sexes · Updated Feb 18, 2026 · NCT04833894A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Prairie Education and Research Cooperative and HSHS Medical Group, O'Fallon
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06298565Vitaccess Real MG Registry
- HSHS St. Elizabeth's Hospital, O'Fallon
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 29, 2025 · NCT06064461Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
- ZS Associates, Evanston
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 10, 2025 · NCT06866483From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.